Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-10

Clinical Trial Update: Ablation vs Amiodarone for Treatment of AFib in Patients With CHF and an ICD [Phase 4]

View source ↗

Summary

Phase 4 trial comparing ablation versus amiodarone for atrial fibrillation in patients with heart failure and an ICD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amiodarone (amiodarone)
  • Implantable cardioverter defibrillator
  • ablation

Snippet

Sponsor: Texas Cardiac Arrhythmia Research Foundation | Conditions: Heart Failure | Phase 4 | Status: COMPLETED